Compare HALO & PRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HALO | PRI |
|---|---|---|
| Founded | 1998 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 8.5B |
| IPO Year | 2001 | 2009 |
| Metric | HALO | PRI |
|---|---|---|
| Price | $74.99 | $283.80 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 4 |
| Target Price | $78.64 | ★ $294.00 |
| AVG Volume (30 Days) | ★ 1.6M | 214.6K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.72% |
| EPS Growth | N/A | ★ 67.10 |
| EPS | 1.22 | ★ 5.97 |
| Revenue | $151,862,000.00 | ★ $3,291,713,000.00 |
| Revenue This Year | $28.24 | $3.98 |
| Revenue Next Year | $12.56 | $5.08 |
| P/E Ratio | $59.53 | ★ $47.14 |
| Revenue Growth | N/A | ★ 6.56 |
| 52 Week Low | $51.06 | $230.09 |
| 52 Week High | $82.22 | $288.03 |
| Indicator | HALO | PRI |
|---|---|---|
| Relative Strength Index (RSI) | 66.87 | 57.64 |
| Support Level | $62.53 | $255.20 |
| Resistance Level | $79.50 | $284.59 |
| Average True Range (ATR) | 2.20 | 5.26 |
| MACD | 0.30 | 0.70 |
| Stochastic Oscillator | 84.09 | 76.08 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.